Initiation of Penumbra, Inc.’s THERAPY Trial Announced at the Society of NeuroInterventional Surgery’s 8th Annual Meeting in Colorado Springs, CO

ALAMEDA, Calif.--(BUSINESS WIRE)--The THERAPY trial, a Penumbra-sponsored groundbreaking trial designed to prove the clinical benefit of interventional treatment of acute ischemic stroke (AIS) was announced today by the trial’s Principal Investigator J Mocco, MD, MS, Assistant Professor of Neurosurgery, The University of Florida, Gainesville, FL.

MORE ON THIS TOPIC